A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Alan K Burnett, Donald Milligan, Archie G Prentice, Anthony H Goldstone, Mary F McMullin, Robert K Hills, Keith Wheatley

Research output: Contribution to journalArticle

412 Citations (Scopus)
Original languageEnglish
Pages (from-to)1114-1124
Number of pages11
JournalCancer
Volume109
Issue number6
DOIs
Publication statusPublished - 15 Mar 2007

Keywords

  • Acute Disease
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Cytarabine
  • Female
  • Humans
  • Hydroxyurea
  • Leukemia, Myeloid
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes
  • Risk
  • Survival
  • Treatment Outcome
  • Tretinoin

Cite this